Highlights and Quick Summary
- EBT margin for the quarter ending June 30, 2022 was 21.63% (a -105.05% decrease compared to previous quarter)
- Year-over-year quarterly EBT margin decreased by -120.08%
- Annual EBT margin for 2021 was 123.96% (a 70.3% increase from previous year)
- Annual EBT margin for 2021 was 72.79% (a -273.97% decrease from previous year)
- Annual EBT margin for 2020 was -41.84% (a -0.0% decrease from previous year)
- Twelve month EBT margin ending June 30, 2022 was 11.62% (a -251.5% decrease compared to previous quarter)
- Twelve month trailing EBT margin decreased by -120.94% year-over-year
Trailing EBT margin for the last four month:
| 30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
|---|---|---|---|
| 11.62% | -7.67% | 68.21% | -55.49% |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT margin of Biofrontera AG Sponsored ADR
Most recent EBT marginof BFAGY including historical data for past 10 years.Interactive Chart of EBT margin of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR EBT margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | 21.63% | -427.96% | – |
| 2021 | 345.0% | -107.73% | -51.99% | -88.99% | 123.96% |
| 2020 | -11.16% | -135.82% | 2.75% | -84.94% | -41.84% |
| 2019 | – | -18.46% | -224.05% | -38.73% | -15.28% |
| 2018 | – | – | – | -81.82% | -91.29% |
| 2017 | – | – | -252.53% | -134.26% | -133.9% |
| 2016 | 100.0% | – | – | – | -172.58% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic